These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30756424)

  • 1. Measurement of microvascular cerebral blood volume changes over the cardiac cycle with ferumoxytol-enhanced T
    Rivera-Rivera LA; Johnson KM; Turski PA; Wieben O; Schubert T
    Magn Reson Med; 2019 Jun; 81(6):3588-3598. PubMed ID: 30756424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
    Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
    Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of cerebral blood volume using quantitative susceptibility mapping, R
    Rivera-Rivera LA; Schubert T; Johnson KM
    NMR Biomed; 2019 Dec; 32(12):e4175. PubMed ID: 31482602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
    Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
    Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a motion-robust 2D chemical shift-encoded technique for R2* and field map quantification in ferumoxytol-enhanced MRI of the placenta in pregnant rhesus macaques.
    Zhu A; Reeder SB; Johnson KM; Nguyen SM; Golos TG; Shimakawa A; Muehler MR; Francois CJ; Bird IM; Fain SB; Shah DM; Wieben O; Hernando D
    J Magn Reson Imaging; 2020 Feb; 51(2):580-592. PubMed ID: 31276263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
    Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
    Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
    Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
    Muehe AM; Feng D; von Eyben R; Luna-Fineman S; Link MP; Muthig T; Huddleston AE; Neuwelt EA; Daldrup-Link HE
    Invest Radiol; 2016 Apr; 51(4):221-227. PubMed ID: 26656202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.
    Iv M; Samghabadi P; Holdsworth S; Gentles A; Rezaii P; Harsh G; Li G; Thomas R; Moseley M; Daldrup-Link HE; Vogel H; Wintermark M; Cheshier S; Yeom KW
    Radiology; 2019 Jan; 290(1):198-206. PubMed ID: 30398435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
    Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
    Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS
    Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
    Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
    Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal brain: regional variability of in vivo MR imaging relaxation rates at 3.0 T--initial experience.
    Williams LA; Gelman N; Picot PA; Lee DS; Ewing JR; Han VK; Thompson RT
    Radiology; 2005 May; 235(2):595-603. PubMed ID: 15858099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE; Nesbit GM; Dosa E; Gahramanov S; Rooney B; Nesbit EG; Raines J; Neuwelt EA
    AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated ferumoxytol-enhanced 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) cardiovascular MRI: validation in pediatric congenital heart disease.
    Zhou Z; Han F; Rapacchi S; Nguyen KL; Brunengraber DZ; Kim GJ; Finn JP; Hu P
    NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27862507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
    Mulholland AD; Vitorino R; Hojjat SP; Ma AY; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
    Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
    Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
    Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.